Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study

Detalles Bibliográficos
Autores principales: Huang, Tang-Hsiu, Kuo, Chin-Wei, Chen, Chian-Wei, Tseng, Yau-Lin, Wu, Chao-Liang, Lin, Sheng-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186065/
https://www.ncbi.nlm.nih.gov/pubmed/34103038
http://dx.doi.org/10.1186/s12890-021-01559-7
Descripción
Sumario:

Ejemplares similares